Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86,559,040
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
15,085,582
-
Shares change
-
-2,086,760
-
Total reported value, excl. options
-
$105,898,739
-
Value change
-
-$23,251,843
-
Put/Call ratio
-
1.14%
-
Number of buys
-
48
-
Number of sells
-
-28
-
Price
-
$7.02
Significant Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q2 2018
98 filings reported holding SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share as of Q2 2018.
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15,085,582 shares
of 86,559,040 outstanding shares and own 17.43% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (3,346,356 shares), MPM ASSET MANAGEMENT LLC (2,168,691 shares), BlackRock Inc. (1,670,816 shares), BVF INC/IL (1,233,618 shares), VANGUARD GROUP INC (762,940 shares), FMR LLC (560,202 shares), DIMENSIONAL FUND ADVISORS LP (558,725 shares), ORBIMED ADVISORS LLC (437,000 shares), 683 Capital Management, LLC (375,000 shares), and Alyeska Investment Group, L.P. (338,789 shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.